Back to catalogue
IKA
Ilika PLC
300/1000 Overall fit
AI beneficiary 35% 25
Operating leverage 25% 33
Valuation 25% 30
Downside protection 15% 38
First-pass take
Pre-revenue solid-state battery developer with no AI exposure. Stereax (medical) and Goliath (EV) target large markets but neither has achieved commercial traction; £0.1m non-grant revenue in 2025 vs £5.2m annual burn. Success dependent on unproven OEM partnerships and regulatory clearances (3-5 year medical ramp).
Flags
pre-revenueloss-makingnet-cashtechnology-riskregulatory-riskgrant-dependentearly-stage